Cytosorbents Corp Files 8-K
Ticker: CTSO · Form: 8-K · Filed: Jun 24, 2025 · CIK: 1175151
| Field | Detail |
|---|---|
| Company | Cytosorbents CORP (CTSO) |
| Form Type | 8-K |
| Filed Date | Jun 24, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, corporate-disclosure
TL;DR
CYTOSORBENTS FILED AN 8-K - STANDARD DISCLOSURE.
AI Summary
Cytosorbents Corporation filed an 8-K on June 24, 2025, reporting other events and financial statements. The filing does not contain specific details on new events or financial figures but serves as a standard corporate disclosure.
Why It Matters
This filing indicates Cytosorbents Corporation is making a required disclosure to the SEC, which could pertain to various corporate events or financial updates.
Risk Assessment
Risk Level: low — The filing is a routine 8-K without immediate negative or positive financial implications detailed within the provided text.
Key Players & Entities
- Cytosorbents Corporation (company) — Registrant
- June 24, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 001-36792 (identifier) — Commission File Number
- 98-0373793 (identifier) — I.R.S. Employer Identification No.
- 305 College Road East Princeton, New Jersey 08540 (address) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing by Cytosorbents Corporation?
The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of June 24, 2025.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on June 24, 2025.
In which state is Cytosorbents Corporation incorporated?
Cytosorbents Corporation is incorporated in Delaware.
What is the Commission File Number for Cytosorbents Corporation?
The Commission File Number for Cytosorbents Corporation is 001-36792.
What is the principal executive office address for Cytosorbents Corporation?
The principal executive office address for Cytosorbents Corporation is 305 College Road East, Princeton, New Jersey 08540.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 24, 2025 regarding Cytosorbents Corp (CTSO).